| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ad2c3ae25b41cc271f47cb85df4278d1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_777d195e1778142c0d570a938a250408
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e38b6ff26c2943a4acea4e9b7910e9ba
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_79c12600f81618559449986b5eed73ff
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_079b9b72e6b22a31fc7bac3de4305f75
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a0674c99d1c4e3f95017ab359aa66775 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-37
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-5406
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-57
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-5428 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-56961
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-56972 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-569 |
| filingDate |
2011-11-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2016-03-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8daed15157a8eefa976dab7ed6bef7fb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_78b01bc0c21d3b670b521566b7f5c2c7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bedd83f01826d671fb140358c6eed07c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_713757ca821d5b90b60915bb5d422daf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_46ba38a540d7c3ce9723839b68183918 |
| publicationDate |
2016-03-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-9274111-B2 |
| titleOfInvention |
Method for the diagnosis of and/or monitoring mucormycosis |
| abstract |
A method is described for the diagnosis and/or monitoring of active or previous infection by Mucor which consists in the identification of Mucorales-specific T cells in samples from biological fluids taken from the patient and put into contact with a Mucor antigen. These specific immune responses can be detected by the execution of immunoenzymatic assays (ELISPOT, Quantiferon) or of immunocytofluorimetric assays [Cytokine Secretion Assay (CSA), Intracellular Cytokine Staining (ICS)] in vitro. In greater detail, the method in question provides for checking for the presence of specific IFN-γ producing T cells, of specific IL-10 producing T cells and/or specific IL-4 producing T cells. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10107822-B2 |
| priorityDate |
2010-12-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |